Zacks.com on MSN3d
Philip Morris Resilient on Smoke-Free Transition Efforts and Pricing
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...
Philip Morris: Growth Potential in Smoke-Free Product Portfolio Fuels Buy Rating
Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...
Nasdaq3d
Philip Morris Resilient on Smoke-Free Transition Efforts and Pricing
Philip Morris International Inc. PM has been making significant strides toward a smoke-free future. With a strong pricing strategy, innovative smoke-free products and disciplined cost-saving ...
Philip Morris Gains Competitive Edge with FDA Authorization of ZYN Nicotine Pouches
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Brookstone Capital Management Has $3.20 Million Stake in Philip Morris International Inc. (NYSE:PM)
Brookstone Capital Management increased its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by ...
Philip Morris International Inc. (NYSE:PM) Stock Position Boosted by Moody National Bank Trust Division
Moody National Bank Trust Division grew its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by ...
Morningstar2d
Philip Morris's Zyn nicotine pouch isn't safe, but FDA gives OK to marketing it
FDA authorizes the marketing of 20 Zyn products because they pose fewer health risks than cigarettes and most smokeless products Shares of Philip Morris ... of all oral smoke-free products and ...